Table 3 General Characteristics of Study Population by Hospitalizations and All-Cause Mortality.

From: Hospitalizations and mortality among patients with fetal alcohol spectrum disorders: a prospective study

 

Hospitalization

All-Cause Mortality

Yes

No

RR

95% CI

PAR %

Yes

No

RR

95% CI

PAR %

n

%

n

%

Lower

 

Upper

n

%

n

%

Lower

 

Upper

Fetal Alcohol Spectrum Disorder

None

1,673

10.80

13,842

89.2

1.00

–

 

–

 

736

4.7

14,779

95.3

1.00

–

 

–

 

Fetal Alcohol Spectrum Disorder

853

27.50

2,250

72.5

2.55

2.37

–

2.74

20.52

387

12.5

2,716

87.5

2.63

2.63

–

2.63

21.35

Sex

Male

1,197

13.20

7,860

86.8

1.00

–

 

–

 

616

6.8

8,441

93.2

1.00

–

 

–

 

Female

1,329

13.90

8,232

86.1

1.05

0.98

–

1.13

2.59

507

5.3

9,054

94.7

0.78

0.78

–

0.78

–12.76

Age at Baseline

 < 20

424

7.60

5,141

92.4

1.00

–

 

–

 

8

0.1

5,557

99.9

1.00

–

 

–

 

20–29

257

9.60

2,415

90.4

1.26

1.09

–

1.46

7.84

12

0.4

2,660

99.6

3.12

3.12

–

3.12

40.79

30–39

336

10.90

2,755

89.1

1.43

1.25

–

1.63

13.22

27

0.9

3,064

99.1

6.08

6.08

–

6.08

64.45

40–49

414

14.60

2,424

85.4

1.91

1.69

–

2.18

23.60

72

2.5

2,766

97.5

17.65

8.51

–

36.59

84.90

50–59

320

17.60

1,499

82.4

2.31

2.02

–

2.64

24.38

125

6.9

1,694

93.1

47.80

23.44

–

97.51

92.02

60–69

370

24.80

1,120

75.2

3.26

2.87

–

3.70

32.30

212

14.2

1,278

85.8

98.97

48.97

–

200.03

95.39

 ≥ 70

405

35.40

738

64.6

4.65

4.12

–

5.25

38.35

667

58.4

476

41.6

405.93

202.76

–

812.71

98.57

Income

None

115

22.40

398

77.6

1.00

–

 

–

 

111

21.6

402

78.4

1.00

–

 

–

 

Low

320

14.95

1,820

85

1.25

1.04

–

1.51

14.81

138

6.4

2,002

93.6

0.30

0.24

–

0.38

–130.54

Medium–low

392

13.97

2,414

86

2.17

1.82

–

2.59

41.68

147

5.2

2,659

94.8

0.24

0.19

–

0.30

–178.35

Medium

455

12.50

3,185

87.5

0.56

0.46

–

0.67

–63.33

173

4.8

3,467

95.2

0.22

0.18

–

0.27

–216.41

Medium–high

575

12.79

3,921

87.2

0.57

0.48

–

0.68

–62.74

199

4.4

4,297

95.6

0.20

0.17

–

0.25

–249.62

High

669

13.32

4,354

86.7

0.59

0.50

–

0.71

–58.29

355

7.1

4,668

92.9

0.33

0.27

–

0.40

–157.05

Medical Insurance

Medical Aid

115

22.40

398

77.6

1.74

1.47

–

2.07

3.68

111

21.6

402

78.4

3.31

2.76

–

3.96

10.59

Insurance (Regional)

1,193

13.80

7,439

86.2

1.07

1.00

–

1.16

3.45

392

4.5

8,240

95.5

0.69

0.61

–

0.78

–17.09

Insurance (Corporate)

1,218

12.90

8,255

87.1

1.00

–

 

–

 

620

6.5

8,853

93.5

1.00

–

 

–

 

Disability Type

None

2,266

12.70

15,599

87.3

1.00

–

 

–

 

828

4.6

17,037

95.4

1.00

–

 

–

 

Mental

171

34.80

321

65.2

2.74

2.41

–

3.11

4.46

184

37.4

308

62.6

8.07

7.07

–

9.21

15.93

Sensory

36

29.50

86

70.5

2.33

1.76

–

3.07

0.89

45

36.9

77

63.1

7.96

6.25

–

10.13

4.51

Intellectual

19

27.50

50

72.5

2.17

1.48

–

3.19

0.45

12

17.4

57

82.6

3.75

2.23

–

6.30

1.05

Other*

34

48.60

36

51.4

3.83

3.00

–

4.89

1.09

54

77.1

16

22.9

16.64

14.41

–

19.22

5.75

Disability Severity

No Disability

2,266

12.70

15,599

87.3

1.00

–

 

–

 

828

4.6

17,037

95.4

1.00

–

 

–

 

Level 1–2

120

39.90

181

60.1

3.14

2.72

–

3.63

3.43

150

49.8

151

50.2

10.75

9.43

–

12.26

13.91

Level 3–6

140

31.00

312

69

2.44

2.12

–

2.82

3.44

145

32.1

307

67.9

6.92

5.96

–

8.04

12.75

Charlson Comorbidity Index

None

280

6.20

4,267

93.8

1.00

–

 

–

 

116

2.6

4,431

97.4

1.00

–

 

–

 

One

412

8.90

4,237

91.1

1.44

1.24

–

1.67

18.17

111

2.4

4,538

97.6

0.94

0.72

–

1.21

-3.35

Two

299

12.10

2,166

87.9

1.97

1.69

–

2.30

25.42

135

5.5

2,330

94.5

2.15

1.68

–

2.74

28.73

 ≥ Three

1,535

22.10

5,422

77.9

3.58

3.17

–

4.05

60.97

761

10.9

6,196

89.1

4.29

3.54

–

5.19

66.54

Region

Metropolitan

764

9.40

7,359

90.6

1.00

–

 

–

 

440

5.4

7,683

94.6

1.00

–

 

–

 

City

609

12.90

4,121

87.1

1.37

1.24

–

1.51

11.95

249

5.3

4,481

94.7

0.97

0.84

–

1.13

–1.05

Other

1,153

20.00

4,612

80

2.13

1.95

–

2.32

0.04

434

7.5

5,331

92.5

1.39

1.22

–

1.58

13.93

Year of Cohort Entry

2003

1,276

11.20

10,122

88.8

1.00

–

 

–

 

632

5.5

10,766

94.5

1.00

–

 

–

 

2004

196

11.30

1,544

88.7

1.01

0.87

–

1.16

0.08

83

4.8

1,657

95.2

0.86

0.69

–

1.08

–1.87

2005

124

13.20

818

86.8

1.18

0.99

–

1.40

1.32

59

6.3

883

93.7

1.13

0.87

–

1.46

0.99

2006

85

12.60

591

87.4

1.12

0.91

–

1.38

0.68

56

8.3

620

91.7

1.08

0.83

–

1.40

0.58

2007

117

19.90

472

80.1

1.77

1.50

–

2.10

3.67

50

8.5

539

91.5

1.53

1.16

–

2.02

2.55

2008

147

20.60

568

79.4

1.84

1.58

–

2.14

4.71

87

12.2

628

87.8

2.20

1.78

–

2.71

6.59

2009

95

19.10

402

80.9

1.71

1.41

–

2.06

2.87

38

7.6

459

92.4

1.38

1.01

–

1.89

1.56

2010

115

21.70

414

78.3

1.94

1.64

–

2.30

4.01

43

8.1

486

91.9

1.47

1.09

–

1.97

2.03

2011

145

24.90

438

75.1

2.22

1.91

–

2.58

5.61

35

6

548

94

1.08

0.78

–

1.51

0.41

2012

128

23.40

418

76.6

2.09

1.78

–

2.46

4.76

28

5.1

518

94.9

0.93

0.64

–

1.34

–0.34

2013

98

24.30

305

75.7

2.17

1.81

–

2.60

3.85

12

3

391

97

0.54

0.31

–

0.94

–1.60

Total

2,526

13.60

16,092

86.4

     

1,123

6

17,495

94

     
  1. *Kidney, musculoskeletal, circulatory, respiratory, nervous system, developmental etc.
Back to article page